drugset / Trial / NCT00681772

Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction

NCT00681772 ↗

Phase 4 Completed 333 enrolled Bayer GlaxoSmithKline · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The aim of this study was to investigate safety, tolerability and efficacy of vardenafil following a flexible dose treatment schedule in subjects with varying aetiology.

Timeline

Start
2003-03
Primary completion
—
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 5 mg —
Subject Vardenafil Small molecule 10 mg —
Subject Vardenafil Small molecule 20 mg —

Indications